Indoco Remedies (NSE:INDOCO, BOM:532612) has received final approval from the US Food and Drug Administration (US FDA) for its Allopurinol Tablets USP, 200 mg, according to a Friday filing to the Indian stock exchanges.
The Allopurinol tablets are a generic equivalent to Casper Pharma's reference-listed drug ZYLOPRIM 200 mg.